Invictus RG (Singapore)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-333
Closed -$20K 69
2015
Q3
$20K Buy
333
+53
+19% +$3.36K 0.02% 485
2015
Q2
$19K Buy
+280
New +$18.5K 0.02% 497
2014
Q3
Sell
-1,097
Closed -$53K 655
2014
Q2
$53K Buy
1,097
+733
+201% +$36.1K 0.06% 387
2014
Q1
$19K Buy
+364
New +$19.4K 0.02% 491

Other funds holding BMY

Invictus RG (Singapore)'s BMY Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 333 shares — an estimated $20K sold.

Invictus RG (Singapore) first reported a position in BMY in Q1 2014 and held it in 4 quarters. The position peaked at $53K in Q2 2014. 1,535 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

  • Invictus RG (Singapore) reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 333 Bristol-Myers Squibb shares in Q4 2015, an estimated $20K.
  • Invictus RG (Singapore) first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 4 quarters.
  • Invictus RG (Singapore)'s Bristol-Myers Squibb position peaked at $53K in Q2 2014.
  • 1,535 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.